PIŚMIENNICTWO
1. Hobi, S, Linek M, Marignac G, et al. Clinical characteristics and causes of pruritus in cats: a muticentre study on feline hypersensitivity-associated dermatosis. Vet Dermatol 2011;22:406-413.
2. Keppel KE, Campbell KL, Zuckermann FA et al. Quantification of canine regulatory T-cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic patients receiving allergen-specific immunotherapy. Vet Immunol Immunopathol 2008;123:332-344.
3. Steffan J, Roberts E, Cannon A, et al. Dose tapering for cyclosporine in cats with nonflea-induced hypersensitivity dermatitis. Vet Dermatol 2013;24:315-322.
4. Cosgrove SB, Wren JA, Cleaver DM et al.Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.Vet Dermatol 2013;24:479-487.
5. Ortalda C, Noli C, Colombo S et al. Oclacitinib in feline nonflea, non-food-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.Vet Dermatol 2015;26:235-e52.
6. Frank RK, Galvan BA, Shoell RA et al. The use of oclacitinib (Apoquel; Zoetis) for the treatment of cutaneous mastocytosis in a cat. Vet Dermatol 2014;25:153. (abstract)
7. Chang CH, Dobam JR, Cohn LA et al. An experimental janus kinase (JAK) inhibitor suppresses eosinophilic airway inflammation in experimental feline asthma. In: Proceedings of the American College of Veterinary Internal Medicine Forum. Seattle, WA, USA: 2013.
8. Noli C, Matricoti I, Schievano C. A double-blinded, randomized, methylprednisolone-controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis. Vet Dermatol 2019;30:110-e30.
9. VanHaaften KA, Eichstadt Forsythe LR, Stelow EA et al. Effects of a single pre-appointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. J Am Vet Med Assoc 2017;251:1175-1182.
